Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
1761
mi
from 02139
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Physician PrimeCare Research
1761
mi
from 02139
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
1763
mi
from 02139
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Diagnostics Research Group
1763
mi
from 02139
San Antonio, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
1600
mi
from 02139
Webster, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
SouthEast Research Institute
1600
mi
from 02139
Webster, TX
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
2088
mi
from 02139
Provo, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
National Clinical Resources, Inc.
2088
mi
from 02139
Provo, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
2092
mi
from 02139
Salt Lake City, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Utah Clinical Trials
2092
mi
from 02139
Salt Lake City, UT
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
488
mi
from 02139
, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Charlottesville Medical Research
488
mi
from 02139
, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
417
mi
from 02139
Manassas, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Manassas Clinical Research Center
417
mi
from 02139
Manassas, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
472
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Dominion Medical Associates
472
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
476
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Associates of Richmond, Inc
476
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
474
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Associates of Richmond, Inc.
474
mi
from 02139
Richmond, VA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
2494
mi
from 02139
Tacoma, WA
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Pulmonary Consultants, Pllc
2494
mi
from 02139
Tacoma, WA
Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Effect of Supplemental Vitamin D on Skeletal Muscle Function in COPD Patients.
Status: Archived
2590
mi
from 02139
Long Beach, CA
Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Effect of Supplemental Vitamin D on Skeletal Muscle Function in COPD Patients.
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Long Beach
2590
mi
from 02139
Long Beach, CA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
2300
mi
from 02139
Phoenix, AZ
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
REM Medical
2300
mi
from 02139
Phoenix, AZ
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
845
mi
from 02139
Chicago, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Northwestern University
845
mi
from 02139
Chicago, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
848
mi
from 02139
Evanston, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
North Shore University Health Systems
848
mi
from 02139
Evanston, IL
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
1079
mi
from 02139
Rochester, MN
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Mayo Center for Sleep Medicine, Mayo Clinic
1079
mi
from 02139
Rochester, MN
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
267
mi
from 02139
Lafayette Hill, PA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
Center for Sleep Medicine
267
mi
from 02139
Lafayette Hill, PA
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
789
mi
from 02139
Columbia, SC
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
Status: Archived
Updated: 1/1/1970
SleepMed of South Carolina
789
mi
from 02139
Columbia, SC
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid"
Status: Archived
1079
mi
from 02139
Rochester, MN
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid"
Status: Archived
Updated: 1/1/1970
Mayo Clinic - Division of Nephrology
1079
mi
from 02139
Rochester, MN
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
356
mi
from 02139
Baltimore, MD
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
356
mi
from 02139
Baltimore, MD
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
544
mi
from 02139
Cleveland, OH
Pre-Operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
Status: Archived
Updated: 1/1/1970
The Cleveland Clinic
544
mi
from 02139
Cleveland, OH
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
174
mi
from 02139
New Hyde Park, NY
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
Updated: 1/1/1970
Interstitial Lung Disease and Pulmonary Hypertension Programs
174
mi
from 02139
New Hyde Park, NY
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
2377
mi
from 02139
Las Vegas, NV
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Nevada Cancer Institute
2377
mi
from 02139
Las Vegas, NV
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
321
mi
from 02139
Hershey, PA
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
321
mi
from 02139
Hershey, PA
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
1545
mi
from 02139
Dallas, TX
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
Phase II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin as First Line Treatment in Patients With Locally Advanced (Stage IIIB With Malignant Pleural Effusion or Pericardial Effusion) or Metastatic (Stage IV) Non-squamous Non Small Cell Lung Cancer (NSCLC)
Status: Archived
Updated: 1/1/1970
Mary Crowley Cancer Research Center
1545
mi
from 02139
Dallas, TX
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
Human Laboratory Model of Cocaine Treatment: Behavioral Economic Analysis: Study 1
Status: Archived
610
mi
from 02139
Detroit, MI
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
Human Laboratory Model of Cocaine Treatment: Behavioral Economic Analysis: Study 1
Status: Archived
Updated: 1/1/1970
Wayne State University
610
mi
from 02139
Detroit, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1048
mi
from 02139
Birmingham, AL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Alabama - Birmingham
1048
mi
from 02139
Birmingham, AL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2597
mi
from 02139
Los Angeles, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
2597
mi
from 02139
Los Angeles, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2692
mi
from 02139
San Francisco, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of California - San Francisco
2692
mi
from 02139
San Francisco, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1761
mi
from 02139
Denver, CO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
National Jewish Medical and Research Center
1761
mi
from 02139
Denver, CO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
118
mi
from 02139
New Haven, CT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
118
mi
from 02139
New Haven, CT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1256
mi
from 02139
Miami, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
1256
mi
from 02139
Miami, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
845
mi
from 02139
Chicago, IL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Chicago
845
mi
from 02139
Chicago, IL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
821
mi
from 02139
Louisville, KY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
821
mi
from 02139
Louisville, KY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1356
mi
from 02139
New Orleans, LA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Tulane University Medical Center
1356
mi
from 02139
New Orleans, LA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
644
mi
from 02139
Ann Arbor, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
644
mi
from 02139
Ann Arbor, MI
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1079
mi
from 02139
Rochester, MN
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1247
mi
from 02139
Kansas City, MO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
ST. Luke's Hospital
1247
mi
from 02139
Kansas City, MO
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
184
mi
from 02139
New York, NY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Cornell University, Weill Medical College
184
mi
from 02139
New York, NY
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2679
mi
from 02139
Oakland, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Highland Hospital
2679
mi
from 02139
Oakland, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
601
mi
from 02139
Durham, NC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1241
mi
from 02139
Weston, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
1241
mi
from 02139
Weston, FL
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
270
mi
from 02139
Philadelphia, PA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
270
mi
from 02139
Philadelphia, PA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
819
mi
from 02139
Charleston, SC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
819
mi
from 02139
Charleston, SC
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2631
mi
from 02139
Ventura, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
2631
mi
from 02139
Ventura, CA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
1547
mi
from 02139
Dallas, TX
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
1547
mi
from 02139
Dallas, TX
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2088
mi
from 02139
Salt Lake City, UT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Utah
2088
mi
from 02139
Salt Lake City, UT
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
2461
mi
from 02139
Seattle, WA
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Status: Archived
Updated: 1/1/1970
University of Washington
2461
mi
from 02139
Seattle, WA
Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
The Role of Endorphins in the Perception of Dyspnea With Resistive Loading in Patients With COPD
Status: Archived
152
mi
from 02139
Darien, CT
Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
The Role of Endorphins in the Perception of Dyspnea With Resistive Loading in Patients With COPD
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
152
mi
from 02139
Darien, CT
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
1255
mi
from 02139
Little Rock, AR
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
Status: Archived
Updated: 1/1/1970
University of Arkansas
1255
mi
from 02139
Little Rock, AR